Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
US Court of Appeals affirms decision finding SEROQUEL XR formulation patent valid and infringed
-
AstraZeneca PLC Fourth quarter and full year results 2012
-
AstraZeneca announces changes to Senior Executive Team
-
CRESTOR US patent upheld by Court of Appeals for the Federal Circuit
-
AstraZeneca announces top-line results of OSKIRA-4 Phase IIb study of fostamatinib as a monotherapy for rheumatoid arthritis
-
AstraZeneca and Isis Pharmaceuticals form strategic alliance on RNA therapeutics for cancer
-
FORXIGA™ (dapagliflozin) now approved in European Union for treatment of type 2 diabetes
-
Court in Germany finds SEROQUEL XR® formulation patent invalid
-
Definition of Core Financial Measures
-
AstraZeneca announces top-line phase III results from naloxegol pivotal trials in patients with opioid-induced constipation
Latest articles and press releases
All of our latest press releases and articles are available to explore
